Form 8-K - Current report:
SEC Accession No. 0001213900-19-026593
Filing Date
2019-12-19
Accepted
2019-12-19 17:15:43
Documents
1
Period of Report
2019-12-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121819_actiniumpharma.htm 8-K 35236
  Complete submission text file 0001213900-19-026593.txt   36403
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 191296676
SIC: 2834 Pharmaceutical Preparations